Tributary Capital Management LLC boosted its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 3.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 214,567 shares of the company's stock after purchasing an additional 7,436 shares during the quarter. Addus HomeCare comprises approximately 1.9% of Tributary Capital Management LLC's investment portfolio, making the stock its 18th largest position. Tributary Capital Management LLC owned about 1.18% of Addus HomeCare worth $21,219,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Segall Bryant & Hamill LLC purchased a new position in shares of Addus HomeCare in the 1st quarter valued at $1,624,000. Victory Capital Management Inc. increased its stake in shares of Addus HomeCare by 40.7% during the first quarter. Victory Capital Management Inc. now owns 136,283 shares of the company's stock worth $13,477,000 after acquiring an additional 39,451 shares during the period. Hohimer Wealth Management LLC lifted its stake in shares of Addus HomeCare by 6.3% in the first quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock valued at $253,000 after purchasing an additional 152 shares during the period. MQS Management LLC acquired a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $260,000. Finally, Envestnet Asset Management Inc. increased its stake in shares of Addus HomeCare by 2.4% during the 1st quarter. Envestnet Asset Management Inc. now owns 43,735 shares of the company's stock worth $4,325,000 after purchasing an additional 1,037 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have recently commented on ADUS shares. JMP Securities reiterated a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Seven equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of "Buy" and an average price target of $142.57.
Get Our Latest Stock Report on Addus HomeCare
Insiders Place Their Bets
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president directly owned 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is currently owned by company insiders.
Addus HomeCare Stock Performance
ADUS traded down $2.66 during trading on Friday, hitting $107.03. The company's stock had a trading volume of 136,336 shares, compared to its average volume of 166,386. The business's 50 day simple moving average is $112.44 and its 200-day simple moving average is $109.81. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The firm has a market cap of $1.97 billion, a PE ratio of 24.16, a P/E/G ratio of 1.52 and a beta of 0.81.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The firm had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the previous year, the business posted $1.21 EPS. Addus HomeCare's revenue was up 20.3% on a year-over-year basis. As a group, sell-side analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.